PCDH8 hypermethylation correlated with poorer patient survival in one cohort where it represented a more significant prognostic marker for patient survival than tumor stage, grade or dimension, but was not statically significant in the second cohort, although a trend was present. The gene discussed is PCDH8; the disease is neoplasm.